The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: TAP Pharmaceuticals
Approval Status: Approved December 1997
Treatment for: duodenal ulcers
General Information
The FDA approved a compliance pack containing Prevacid (lansoprazole) delayed-release capsules, clarithromycin tablets, and amoxicillin capsules for eradication of Helicobacter pylori in patients with duodenal ulcers.